Dato-DXd mediates anti-tumor activity in preclinical TROP2-expressing intracranial tumor model

被引：1
|
作者：
Jones, Kristen Jones
Suksomboon, Montira
Rosenthal, SaraAnn
Gordon, Jacob
Reimer, Corinne
Sung, Matthew
Rane, Chetan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1911
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1911
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Datopotamab deruxtecan (Dato-DXd) enhances antitumor response to PD-1/PD-L1 inhibitors in TROP2-expressing tumors in mice
    Okajima, Daisuke
    Yasuda, Satoru
    Suzuki, Takami
    Kitamura, Michiko
    Yamaguchi, Junko
    Maejima, Takanori
    Karibe, Tsuyoshi
    Toki, Tadashi
    Phillips, Penny
    Agatsuma, Toshinori
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Evaluation of bystander antitumor effect of Dato-DXd in TROP2 (+) and TROP2 (-) lung cell lines admixed tumor xenograft mouse models
    Yasuda, Satoru
    Maejima, Takanori
    Toki, Tadashi
    Karibe, Tsuyoshi
    Okajima, Daisuke
    Phillips, Penny
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Eribulin has anti-tumor activity in a preclinical model of merkel cell carcinoma
    Miyamoto, K.
    Yanagi, T.
    Maeda, T.
    Kitamura, S.
    Ujiie, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S41 - S41
  • [4] Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models
    Franklin, M.
    Thayer, M.
    Draper, D.
    Saims, D.
    Wise, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S97 - S97
  • [5] OMX IS A TUMOR MICROENVIRONMENT MODIFIER THAT RESTORES ANTI-TUMOR IMMUNITY AND IMPROVES ANTI-TUMOR EFFICACY BY REDUCING TUMOR HYPOXIA IN INTRACRANIAL GLIOBLASTOMA MOUSE MODEL
    Le Moan, Natacha
    Davis, Tina
    Leung, Philberta
    Ng, Sarah
    Winger, Jonathan
    Cary, Stephen
    Butowski, Nicholas
    Krtolica, Ana
    NEURO-ONCOLOGY, 2018, 20 : 259 - 259
  • [6] AN ALTERNATIVE MODEL FOR THE EVALUATION OF ANTI-TUMOR ACTIVITY
    LAVIN, PT
    CANCER CLINICAL TRIALS, 1981, 4 (04) : 451 - 457
  • [7] ANTI-TUMOR ACTIVITY OF LENTINAN IN A SYNGENEIC MURINE TUMOR-MODEL
    ROSE, WC
    REED, FC
    SIMINOFF, P
    BRADNER, WT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 192 - 192
  • [8] PRECLINICAL ANTI-TUMOR ACTIVITY OF XL880 IN NASOPHARYNGEAL CARCINOMA
    Xie, M.
    Li, Z.
    ANNALS OF ONCOLOGY, 2012, 23 : 337 - 337
  • [9] TETROCARCINS, NOVEL ANTI-TUMOR ANTIBIOTICS .2. ISOLATION, CHARACTERIZATION AND ANTI-TUMOR ACTIVITY
    TAMAOKI, T
    KASAI, M
    SHIRAHATA, K
    OHKUBO, S
    MORIMOTO, M
    MINEURA, K
    ISHII, S
    TOMITA, F
    JOURNAL OF ANTIBIOTICS, 1980, 33 (09): : 946 - 950
  • [10] In vivo programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models
    Argueta, Shannon
    Wang, Yuxiao
    Zhao, Hongyun
    Diwanji, Neha
    Gorgievski, Michael
    Cochran, Edward
    Grudzien-Nogalska, Ewa
    D'Alessandro, Josephine
    Mccreedy, Bruce
    Prod'homme, Thomas
    Hofmeister, Robert
    Ding, Jian
    Getts, Daniel
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345